Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 199 results.

Selected filters: Media

Displaying 51 to 60 of 199 records
Sort by: Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>

SNMMI Elects Jean-Luc C. Urbain, MD, PhD, FASNC, as Vice President-Elect at 2023 Annual Meeting – Jun 26, 2023
Jean-Luc C. Urbain, MD, PhD, FASNC, professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo in New York, has been elected vice president-elect for the SNMMI.
Umar Mahmood, MD, PhD, Receives First Annual SNMMI Minoshima-Pappas Transformational Leadership Award – Jun 26, 2023
Umar Mahmood, MD, PhD, chief of Nuclear Medicine and Molecular Imaging, director of the Center for Precision Imaging, and associate chair for imaging sciences in the Department of Radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School in Boston, has been named as the first recipient of the new Minoshima-Pappas Transformational Leadership Award.
Peter J. H. Scott, PhD, Receives SNMMI Sam Gambhir Trailblazer Award – Jun 26, 2023
Peter J. H. Scott, PhD, associate professor of radiology and pharmacology, division director of nuclear medicine, and director of the PET Center at the University of Michigan in Ann Arbor, Michigan, has been named as the 2023 recipient of the Sam Gambhir Trailblazer Award.
SNMMI Image of the Year: New Theranostic Pair Facilitates Early Detection and Effective Treatment of Pancreatic Cancer – Jun 26, 2023
A first-in-human evaluation of the novel theranostic pair Ga-68 DOTA-5G / Lu-177 DOTA-ABM-5G has confirmed its ability to successfully detect metastatic pancreatic cancer and visualize targeted treatment of the disease. A grouping of the resulting images has been selected as the 2023 SNMMI Henry N. Wagner, Jr., Image of the Year.
Novel Radiotracer Accurately Detects and Differentiates Renal Cell Carcinomas – Jun 26, 2023
A new PET tracer, Zr-89 DFO-girentuximab, can accurately detect a type of kidney cancer called clear cell renal cell carcinoma and differentiate it from other types of kidney tumors.
New Radiopharmaceutical Therapy Target Identified for Metastatic Bladder Cancer – Jun 26, 2023
A new therapeutic target has been discovered for metastatic bladder cancer, opening up the door for more effective detection and treatment of this deadly disease.
Society of Nuclear Medicine and Molecular Imaging Announces 2023 Fellows – Jun 26, 2023
SNMMI recognized ten new SNMMI Fellows today during a plenary session at the societys 2023 Annual Meeting.
SNMMI and IAC Collaborate on New Radiopharmaceutical Therapy Accreditation Program – Jun 25, 2023
SNMMI and the Intersocietal Accreditation Commission are pleased to announce an enhanced partnership that will help ensure quality care for patients receiving radiopharmaceutical therapy.
Nizar A. Mullani, BS, Receives SNMMI 2023 Georg Charles de Hevesy Nuclear Pioneer Award – Jun 25, 2023
Nizar A. Mullani, BS, one of the pioneers of the first positron emission tomography (PET) prototype, has been named as this years recipient of the Georg Charles de Hevesy Nuclear Pioneer Award.
Henry VanBrocklin, PhD, FSNMMI, FSRS, Receives SNMMI 2023 Paul C. Aebersold Award for Outstanding Achievement in Basic Nuclear Medicine Science – Jun 25, 2023
Henry VanBrocklin, PhD, has been named the 2023 recipient of the prestigious Paul C. Aebersold Award.

Displaying 51 to 60 of 199 records
Page: << Prev 3… 4… 5… 6… 7… 8… 9… Next >>